Schrödinger’s mission is to revolutionize drug discovery through the use of breakthrough computational methods applied to drug design. We are currently looking for outstanding interns to join our Competitive Intelligence team. The participants will be responsible for biopharmaceutical ecosystem and competitive landscape analysis for targets and programs of interest to Schrödinger’s Discovery and Development group. The intern will assist in generating knowledge maps for potential programs and analyzing trends, emerging data & opportunities related to existing programs in a highly dynamic and cooperative environment.
Our drug discovery group of over 70 scientists includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists with decades of combined drug discovery experience. The group is supported by more than 100 software developers and engineers. Three of the programs Schrödinger has worked on in the past 7 years have progressed into the clinic and one received FDA approval earlier this year.
- Perform target landscape analyses to identify potential programs for unmet medical needs within select therapeutic areas
- Gather information from reliable sources (e.g. PubMed, OVID, Cortellis, EvaluatePharma, BioMedTracker, Citeline, EDGAR, RePORTER) and aggregators (e.g. Crunchbase), generate routine informational alerts as well as perform ad hoc searching on-demand
- Collect and analyze data on preclinical and clinical development publications and pipelines, recent acquisition/licensing deals, conference proceedings and patents to assess the competitive landscape and build a scientific and business case for potential therapeutic programs.
- Interpret data from public industry and analyst reports, and private databases and identify emerging science and target opportunities
- Work closely with the drug discovery and business development teams, as well as data science and library professionals; and externally, by networking with industry experts to gather insights
- Effectively capture competitive intelligence and synthesize insights, then disseminate and communicate insights and intelligence to relevant stakeholders, including leadership, in a timely manner
- Currently completing or recently completed a Master’s in Business Administration with Healthcare, Biotech or Pharmaceutical focus
- Bachelor’s in Life Science or other relevant science experience
- Strong analytical and critical thinking skills with the ability to interpret large amounts of data and distill and communicate key themes/messages/information
- Some familiarity with market and asset research techniques, due diligence and financial modeling
- Demonstrated ability as a detail-oriented self-starter who can work as a cross-functional team member and can deliver results and insights in a timely manner
- Strong communication, presentation, and interpersonal skills
We are prepared to offer a highly competitive compensation package and a flexible work environment for an exceptionally well-qualified candidate. Benefits include medical, dental, 401(k), flexible spending account, 4+ weeks vacation, and tuition reimbursement.
As an equal opportunity employer, Schrödinger hires outstanding individuals into every position in the company. People who work with us have a high degree of engagement, a commitment to working effectively in teams, and a passion for the company's mission. We place the highest value on creating a safe environment where our employees can grow and contribute, and refuse to discriminate on the basis of race, color, religious belief, sex, age, disability, national origin, alienage or citizenship status, marital status, partnership status, caregiver status, sexual and reproductive health decisions, gender identity or expression, or sexual orientation. To us, "diversity" isn't just a buzzword, but an important element of our core principles and key business practices. We believe that diverse companies innovate better and think more creatively than homogenous ones because they take into account a wide range of viewpoints. For us, greater diversity doesn't mean better headlines or public images - it means increased adaptability and profitability.